- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BrightPath Biotherapeutics Co Ltd (4594)
BrightPath Biotherapeutics Co Ltd stock price live, this page displays TYO 4594 stock exchange data. View the 4594 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BrightPath Biotherapeutics Co Ltd real time stock price chart below.
What Is the BrightPath Biotherapeutics Co Ltd Stock Price Today?
The BrightPath Biotherapeutics Co Ltd stock price today is 52.0.
What Is the Stock Symbol for BrightPath Biotherapeutics Co Ltd?
The stock symbol for BrightPath Biotherapeutics Co Ltd is "4594."
What Stock Exchange Does BrightPath Biotherapeutics Co Ltd Trade On?
BrightPath Biotherapeutics Co Ltd is listed and trades on the Tokyo stock exchange.
Is BrightPath Biotherapeutics Co Ltd a Good Stock to Buy?
Determining whether BrightPath Biotherapeutics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4594 quote. (ISIN: JP3274140007)
What Is the BrightPath Biotherapeutics Co Ltd Stock Price Today?
The BrightPath Biotherapeutics Co Ltd stock price today is 52.0.
What Is the Stock Symbol for BrightPath Biotherapeutics Co Ltd?
The stock symbol for BrightPath Biotherapeutics Co Ltd is "4594."
What Stock Exchange Does BrightPath Biotherapeutics Co Ltd Trade On?
BrightPath Biotherapeutics Co Ltd is listed and trades on the Tokyo stock exchange.
Is BrightPath Biotherapeutics Co Ltd a Good Stock to Buy?
Determining whether BrightPath Biotherapeutics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4594 quote. (ISIN: JP3274140007)
Tokyo
Currency in JPY
52.0
+1.0(+1.96%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.0
52.0
52 wk Range
43.0
96.0
4594 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.052.0
52 wk Range
43.096.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4594 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
-3.82 / --
Revenue / Forecast
-- / --
Compare 4594 to Peers and Sector
Metrics to compare | 4594 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4594PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.4x | −8.8x | −0.4x | |
PEG Ratio | −0.32 | −0.14 | 0.00 | |
Price/Book | 3.0x | 2.9x | 2.6x | |
Price / LTM Sales | 84,326.8x | 18.2x | 3.0x | |
Upside (Analyst Target) | - | 107.7% | 47.5% | |
Fair Value Upside | Unlock | 11.8% | 6.7% | Unlock |
BrightPath Biotherapeutics Co., Ltd. engages in the development of cancer immunotherapy drugs in Japan. The company is developing BP2201, a product candidate in Phase I clinical trials to target cancer antigens in various types of cancer; BP2202, Phase I clinical trial to target cancer; and BP2301, a product candidate in Phase I clinical trials for the treatment of solid tumors sarcoma and gynecological cancers. In addition, its product candidates in preclinical trials include BP1200 that targets CD73; BP1202 that targets acute myeloid leukemia; BP1210, which suppresses T cell cytotoxicity; BP1212 to inhibit TIM-3 and CD39; BP1209 to target tumor-specific neo-antigens; and BP1223 to target blood cancers. The company was formerly known as GreenPeptide Co., Ltd. and changed its name to BrightPath Biotherapeutics Co., Ltd. in July 2017. The company was incorporated in 2003 and is headquartered in Kawasaki, Japan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the BrightPath Biotherapeutics (4594) Stock Price Today?
The BrightPath Biotherapeutics stock price today is 52.0 JPY.
What Stock Exchange Does BrightPath Biotherapeutics Trade On?
BrightPath Biotherapeutics is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for BrightPath Biotherapeutics?
The stock symbol for BrightPath Biotherapeutics is "4594."
What Is the BrightPath Biotherapeutics Market Cap?
As of today, BrightPath Biotherapeutics market cap is 7.08B JPY.
What Is BrightPath Biotherapeutics's Earnings Per Share (TTM)?
The BrightPath Biotherapeutics EPS (TTM) is -11.7.
When Is the Next BrightPath Biotherapeutics Earnings Date?
BrightPath Biotherapeutics will release its next earnings report on Nov 06, 2026.
From a Technical Analysis Perspective, Is 4594 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has BrightPath Biotherapeutics Stock Split?
BrightPath Biotherapeutics has split 0 times.
How Many Employees Does BrightPath Biotherapeutics Have?
BrightPath Biotherapeutics has 42 employees.
What is the current trading status of BrightPath Biotherapeutics (4594)?
As of Sep 07, 2026, BrightPath Biotherapeutics (4594) is trading at a price of 52.0 JPY, with a previous close of 51.0 JPY. The stock has fluctuated within a day range of 50.0 JPY to 52.0 JPY, while its 52-week range spans from 43.0 JPY to 96.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.